Sign in

Neurodata.tokyo

@neurodata.tokyo
121 followers 60 following 210 posts

データサイエンティスト、AIエンジニア、研究者などからなる小規模なプライベートコミュニティ。研究データ解析や生成AI活用支援も行っています。Blueskyでは生命科学・医歯薬学、機械学習、研究ソフトウェアの情報を不定期に共有。ご相談はWebサイトへ。 neurodata.tokyo

PostsRepliesMedia
Neurodata.tokyo @neurodata.tokyo · 24/09/2026
FDA が、first-in-human 試験の立ち上げ加速を狙う「Expedited IND Pilot」の最終設計を公表&申請受付を開始しました。臨床開発のスピード・品質・安全性をどう担保していくか、今後注目です👀 www.fda.gov/industry/fda...
fda.gov
FDA Expedited Investigational New Drug Pilot Program
Accelerating Early-Stage Clinical Research in the U.S.
010
Neurodata.tokyo @neurodata.tokyo · 17/09/2026
bioRxivに、13研究・791人・>300万nuclei を統合したAlzheimer’s disease single-nucleus atlasの報告。研究間で再現する細胞種特異的なプログラムと、患者ごとの分子サブタイプを整理しています。 www.biorxiv.org/content/10.6...
biorxiv.org
An Integrated Single-Nucleus Atlas Resolves Cell-Type-Specific Programs and Molecular Subtypes in Alzheimer’s Disease
Interindividual heterogeneity in Alzheimer’s disease (AD) remains poorly understood, as disparate single-cell studies leave it unclear whether findings reflect shared architecture or dataset-specific ...
010
Neurodata.tokyo @neurodata.tokyo · 17/09/2026
native long-read sequencing の DNA methylation を内因性バーコードとして使い、組織中の体細胞変異を細胞種ごとに割り当てる手法の提案。single-cell 実験を追加せず、bulk のロングリードシーケンスから変異がどの細胞で起きたかまで追える時代になっていく予感です。 www.medrxiv.org/content/10.6...
medrxiv.org
Cell-type-resolved somatic variant discovery from bulk long-read sequencing
Somatic mutations arise throughout life, with functional consequences tied to the cell populations in which they occur. Genome-wide studies measure somatic variations in bulk tissue, whereas single-ce...
020
Neurodata.tokyo @neurodata.tokyo · 17/09/2026
染色画像・空間トランスクリプトミクス・scRNA-seq reference を統合し、細胞のセグメンテーションと細胞型のアノテーションを同時に行う手法 "CellART" の提案 www.biorxiv.org/content/10.6...
biorxiv.org
CellART: a unified framework for extracting single-cell information from high-resolution spatial transcriptomics
Understanding how different cell types assemble into tissues and organs, as well as how they interact to transmit and receive biological signals, is essential for advancing biomedical and biological r...
010
Neurodata.tokyo @neurodata.tokyo · 02/09/2026
ニュース記事はこちら www.ebi.ac.uk/about/news/u...
ebi.ac.uk
Ensembl rolls out new website
The website URL remains www.ensembl.org. This updated website offers new scientific opportunities, as genomes and genesets are now available for a diverse array of species from across the tree of life...
000
Neurodata.tokyo @neurodata.tokyo · 02/09/2026
EMBL-EBI が Ensembl の新Webサイトも公開。Ensembl 116 / Ensembl Genomes 63 のgenesetが含まれます。 www.ensembl.org
ensembl.org
Ensembl
The new website of the Ensembl project
110
Neurodata.tokyo @neurodata.tokyo · 02/09/2026
EMBL-EBI の AMR Portal Release 2026_07 が公開。新しい検索機能、genome browser、genotype annotation拡張が追加されています。 AMRのような公衆衛生領域では、解析モデルだけでなく、ゲノム・表現型・アノテーションを簡便に接続できるデータ基盤が研究と政策の土台に。 www.ebi.ac.uk/about/news/u...
ebi.ac.uk
AMR Portal Release 2026_07 is live
Antimicrobial resistance (AMR) Portal updated with new search, genome browser and annotations
020
Neurodata.tokyo @neurodata.tokyo · 02/09/2026
FDA が generative AI-enabled medical devices の規制方針に向け、discussion paper を公開し意見募集を開始していました。 生成AIの医療機器への統合はホットなテーマで、日本のSaMD周りも今後どうなっていくのか気になるところです🧐 www.fda.gov/news-events/...
fda.gov
FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices
The U.S. Food and Drug Administration today issued a discussion paper on considerations for the regulation of generative artificial intelligence (GenAI)-enabled medical devices, seeking feedback from ...
131
Neurodata.tokyo @neurodata.tokyo · 02/09/2026
Nature Biotechnology にて、AI大手の生命科学への参入について整理。AI × 生命科学が「論文要約」のような個別ツールから研究基盤・プラットフォーム競争へ移っている流れを俯瞰できます。 www.nature.com/articles/s41...
nature.com
Tech giants plunge into life sciences - Nature Biotechnology
Nature Biotechnology - Tech giants plunge into life sciences
120
Neurodata.tokyo @neurodata.tokyo · 02/09/2026
PMC の Article Dataset Distribution Services に変更があったんですね👀 文献フルテキストを使う研究データ基盤やAI解析パイプラインでは、取得方法の更新確認が必要になっていました。 pmc.ncbi.nlm.nih.gov/tools/textmi...
pmc.ncbi.nlm.nih.gov
PubMed Central: PMC Article Datasets
010
Neurodata.tokyo @neurodata.tokyo · 07/06/2026
医療の大規模言語モデルを使う安全対策の話です。攻撃らしい文だけを検出しても、患者情報の一括出力や別患者データ参照のような、正当に見える危険な依頼は残ります。用途範囲を先に宣言して、外れた要求を止める設計は実装安全性に直結します。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
Beyond Injection Detection: A Positive-Security Prompt Firewall that Closes the Scope and PHI Gap SOTA Classifiers Miss in Healthcare
Large language models embedded in autonomous agents process trusted instructions and untrusted data in one context window, leaving them open to direct and indirect prompt injection. In healthcare this is not hypothetical: a 2025 JAMA Network Open study found commercial medical LLMs followed injected instructions in 94.4% of simulated patient encounters, including life threatening recommendations . Yet the clinically decisive problem we quantify here is different. Most real clinical threats protected health information PHI exfiltration, cross patient access, bulk export, out of scope advice are fluent, legitimate looking requests that carry no attack signal, so even a state of the art injection detector passes them. Existing runtime guardrails trade safety against latency: model based auditors are accurate but add hundreds of milliseconds of Python inference, while lexical filters are fast but blind to obfuscated or semantically disguised payloads. We present QFIRE, an inline, provider
020
Neurodata.tokyo @neurodata.tokyo · 06/06/2026
medRxiv に、Tasso+のcapillary blood microsamplingでGFAPやNfLなど神経バイオマーカーを測る分析バリデーション。遠隔研究では、72時間遅延処理や静脈血との一致まで確認する品質設計が、神経データ基盤の信頼性を左右します。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
Analytical Validation of Minimally Invasive Capillary Blood Microsampling using Tasso+ for Multiplexed Neurological Biomarkers
Blood-based biomarkers are increasingly used to investigate brain health, but collecting venous blood is difficult in remote and field settings. Capillary microsampling offers a practical alternative, although the ability to delay processing and its agreement with gold-standard venous blood require validation. We evaluated Tasso+, a minimally invasive upper-arm capillary blood collection system, for measuring neurological and host-response biomarkers in plasma and serum during an exercise-based protocol. Sampling occurred before, immediately after, and approximately 24-to-36 hours after exercise; Tasso+ samples were processed with or without a 72-hour room-temperature delay. Tasso+ samples were compared with matched venous blood, and Capitainer SEP10 dried plasma spots were also evaluated, using Quanterix Simoa and Alamar Biosciences NULISAseq CNS panel. Tasso+ enabled reliable measurement of several key biomarkers, including GFAP and NfL, even after delayed processing. These findings
010
Neurodata.tokyo @neurodata.tokyo · 05/06/2026
medRxiv に、下垂体手術支援システムの信頼校正を調べた研究。信頼度ラベルやモデル説明を加えた画面では、システムが外した場面で信頼が下がりました。臨床人工知能の安全性は、正解率だけでなく外れた時に人が疑える設計まで含みます。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
Calibrating trust in AI-assisted pituitary surgery
Background: Endoscopic endonasal transsphenoidal surgery (EETS) requires navigation around neurocritical anatomy. Today, artificial intelligence clinical decision support systems (AI-CDSSs) can orientate surgeons, but clinician trust in AI remains unclear, limiting safe deployment. This study evaluates how modifiable design affects trust and performance in a real-world pituitary surgery AI-CDSS. Method: Online, 70 clinicians with pituitary surgery experience were randomised evenly to a Basic or Enhanced AI-CDSS which outline the sella on EETS operative video. The Enhanced group additionally received explanation of the model and previous publications, alongside confidence labels depicting outline reliability. Both groups annotated the sella on six video clips, first alone then with the optional AI-CDSS. Clips were ordered by declining AI performance, except for the final clip. Self-reported trust was measured using a 1-7 scale after each annotation, and performance was the DICE overlap
010
Neurodata.tokyo @neurodata.tokyo · 05/06/2026
medRxiv に、下垂体内視鏡手術向けナビゲーションの前臨床評価。19人の脳神経外科医で技術成績は改善した一方、作業負荷も上がりました。臨床人工知能は性能だけでなく人間工学まで評価対象です。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
Real-time Computer Vision Assisted Navigation for Endoscopic Pituitary Surgery: Iterative Development and Comparative Preclinical Evaluation
Background Endoscopic pituitary surgery involves navigating high-stakes anatomy where complications, such as carotid artery injury, cause devastating morbidity. While computer vision AI offers potential for real-time anatomical recognition to mitigate these risks, successful translation requires rigorous human-factors and performance evaluation. We present the iterative development and preclinical evaluation of a surgeon-controlled, real-time AI-assisted navigation system. Methods Guided by IDEAL Stage 0 and DECIDE-AI frameworks, the study was conducted in two phases. Phase 1 was an exploratory study where surgeons used the system during high-fidelity simulated surgery and provided feedback via "Think Aloud" protocols and surveys. Following prototype iteration, a Phase 2 randomized crossover comparative trial was conducted with 19 neurosurgeons (15 trainees, 4 experts) performing high-fidelity simulated tumour resections with and without AI assistance, separated by a minimum 2-week was
010
Neurodata.tokyo @neurodata.tokyo · 05/06/2026
medRxiv に、GPT-5-Chat を用いたカリウム補正提案を20症例で検証した研究。臨床家作成の投与原則を与えても精度は45%から65%までで、高リスク薬剤では単純ルールのベンチマーク通過だけでは安全性評価になりません。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
Don't stop the heart: a performance analysis of large language models and potassium dosing
Background: Electrolyte replacement is ubiquitous in the acute care setting, but its familiarity cannot belie that even small dosing errors with potassium can cause lethal cardiac arrhythmias. Recently, MedAgentBench offered a benchmark for agentic artificial intelligence (AI) including the ability to correctly dose potassium based on a single rule; however, this does not adequately reflect the clinical complexity or safety concerns of an agent that has been used as the lethal injection. The purpose of this analysis was to a probe leaderboard large language model (LLM) capabilities to follow basic dosing rules to safely replace potassium in a series of clinician-annotated cases. Methods: Using a clinician panel, we developed a series of dosing principles and 20 clinical cases reflective of the complexity of potassium replacement. External clinicians were surveyed to assess practice variability and agreement to clinician panel answers. We tested GPT-5-chat with each case in triplicate,
110
Neurodata.tokyo @neurodata.tokyo · 04/06/2026
bioRxivに、低頻度体細胞変異検出を6つの短鎖シーケンスプラットフォームで比較したベンチマーク。cfDNAの1%未満VAFは、AI callerの精度だけでなく、プラットフォーム差・標準試料・再現可能な評価設計までセットで見ないと危ういです。 www.biorxiv.org/content/10.64898/20…
biorxiv.org
Assessing and Optimizing Low-Frequency Somatic Mutation Detection: A Multi-Platform High-Throughput Sequencing Perspective
The availability of multiple commercial short-read sequencing platforms necessitates systematic cross-platform performance comparisons, particularly for challenging applications such as low-frequency somatic mutation detection. Here, a large-scale targeted sequencing dataset from five Genome in a Bottle (GIAB) human genomic DNA reference standards, HG001 to HG005, alongside Twist Biosciences cfDNA reference standards featuring 1% variant allele frequency (VAF), was generated by six platforms (NovaSeq 6000, NovaSeq X, FASTASeq 300, GenoLab M, SURFSeq 5000, and MGISEQ-T7). To build a realistic benchmark while keeping authentic sequencing backgrounds, we developed PosMix, a simulating tool that generates position-specific VAFs. To overcome the limitations of conventional variant callers (high recall with poor precision for VarScan2, higher precision with lower recall for Strelka2/Mutect2), we developed SomaticXGB, a machine learning-based caller. In this study, SURFSeq 5000 consistently e
110
Neurodata.tokyo @neurodata.tokyo · 04/06/2026
medRxivに、未承認retatrutide使用者のReddit投稿をLLMで抽出し、MedDRA症状へ対応づけた安全性研究。治験外のグレーマーケット利用が広がる時、SNS由来データを薬事安全監視へどう接続するかが論点になります。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
Self-Reported Side Effects Among Reddit Users Taking Unapproved Retatrutide
Gray-market retatrutide use is increasing, but patient safety experiences remain poorly characterized. This cross-sectional analysis examined Reddit posts and comments from retatrutide-specific and broader peptide or weight-management communities through December 2025. A validated large language model classified self-reported retatrutide use and extracted author-attributed symptoms mapped to MedDRA Preferred Terms. Among 13,589 users reporting current use, 7,823 had at least one mapped symptom after exclusions. Unlike phase 2 trial findings dominated by gastrointestinal events, Reddit reports most often described appetite increase, fatigue, increased energy, nausea, food craving, insomnia, and elevated heart rate. Findings are hypothesis-generating and warrant pharmacovigilance attention. ### Competing Interest Statement JST reports receiving an investigator-initiated grant, on behalf of the University of Pennsylvania, from Novo Nordisk and receiving consulting fees from Currax Pharm
010
Neurodata.tokyo @neurodata.tokyo · 04/06/2026
medRxivに、digital antimicrobial stewardship介入のRCTメタ解析。デジタル支援は期待されますが、処方適正化や死亡・再入院への効果は非常に低確実性で明確ではない結果。臨床AI/DXは「入れた」より「効いた」を問う段階です。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
Promise vs. Proof in Digital Interventions for Antimicrobial Stewardship: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background: Digital antimicrobial stewardship (AMS) interventions, such as clinical decision support systems, audit and feedback platforms, and electronic prescribing tools, have been increasingly adopted to improve antibiotic use. However, the effectiveness of these interventions across healthcare settings remains uncertain, and the certainty of the evidence has not been comprehensively evaluated. The objective of this study was to provide a comprehensive understanding of the role of digital interventions in optimizing antimicrobial use and improving clinical outcomes within a broad spectrum of healthcare settings. Methods: We conducted a systematic review and meta-analysis of randomized controlled trials evaluating digital AMS interventions that followed PRISMA 2020 guidelines and registered in PROSPERO CRD420251178854 and funded by the Wellcome Trust CAMO Net programme. Searches were performed across major databases. Primary outcomes included the appropriateness of antibiotic prescr
010
Neurodata.tokyo @neurodata.tokyo · 04/06/2026
medRxivにPatientEvent。患者ポータルの自由文メッセージを、8種類のイベントと70の役割で表す臨床オントロジーです。自動トリアージや返信案生成は、LLM以前に「患者が何を開示したか」を構造化できるかが土台になります。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
PatientEvent: An Event-Based Ontology for Patient-Initiated Portal Communication
Patient portal messaging has become a primary channel for asynchronous clinical communication, it spans a wide range of content, from symptom reports and medication concerns to administrative requests. Despite this volume and diversity, there is no formal representation for what a portal message contains: no vocabulary for the clinical and administrative events it describes, or for the attributes of those events that the patient has actually disclosed. Without such a representation, it is difficult to systematically analyze portal communication, assess message completeness, or build downstream tools that depend on structured input, such as automated triage, response drafting, and follow-up question generation. A clinical event schema, grounded in real portal messages and reviewed by clinicians, would provide this missing foundation. We introduce a clinical event ontology for patient portal messages, containing 8 event types and 70 roles that span clinical content (symptoms, medications
010
Neurodata.tokyo @neurodata.tokyo · 01/06/2026
ご質問をありがとうございます!医療系論文はとりあえず何でもAUC/ROCっていうのは現場の実情とは合わないですよね🥲 False alarm rate については、論文紹介で自分で動かしたわけでは無いので、論文以上の知見は持っておらずですみません!🙇
010
Neurodata.tokyo @neurodata.tokyo · 01/06/2026
小児喘息の再救急受診・入院を電子カルテから予測するAIRE-KIDSがnpj Digital Medicineに掲載。機械学習で高リスク児を早く見つけるだけでなく、予防ケアへどう接続するかが臨床実装の勝負どころです。 www.nature.com/articles/s41746-026-…
nature.com
AI for predicting exacerbations in KIDs with asthma (AIRE-KIDS) - npj Digital Medicine
npj Digital Medicine - AI for predicting exacerbations in KIDs with asthma (AIRE-KIDS)
010
Neurodata.tokyo @neurodata.tokyo · 01/06/2026
脳卒中MRIから病変を自動抽出し、個別の認知予後を予測する神経画像プラットフォームがnpj Digital Medicineに掲載。DICOMからテキスト化された予後情報までつなぐ流れは、臨床AIをワークフローに入れる実装例です。 www.nature.com/articles/s41746-026-…
nature.com
A clinical neuroimaging platform for rapid, automated lesion detection and personalized post-stroke outcome prediction - npj Digital Medicine
npj Digital Medicine - A clinical neuroimaging platform for rapid, automated lesion detection and personalized post-stroke outcome prediction
010
Neurodata.tokyo @neurodata.tokyo · 01/06/2026
患者の入院関連質問に対するAI回答を、自動評価で良い回答と悪い回答に分けられるかを検証した研究。医療LLMの評価は「医師が読む」だけではスケールしないので、評価器そのものの妥当性確認が焦点になります。 www.nature.com/articles/s41746-026-…
nature.com
Automated evaluation can distinguish the good and bad AI responses to patient questions about hospitalization - npj Digital Medicine
npj Digital Medicine - Automated evaluation can distinguish the good and bad AI responses to patient questions about hospitalization
010
Neurodata.tokyo @neurodata.tokyo · 01/06/2026
医療AIのデータセット偏りを、画像・表・テキストなどの形式に依存せず監査するG-AUDITがnpj Digital Medicineに掲載。性能検証だけでなく、訓練データに潜む属性の検出可能性まで見る発想が大事です。 www.nature.com/articles/s41746-026-…
nature.com
Detecting dataset bias in medical AI using a generalized and modality agnostic auditing approach - npj Digital Medicine
npj Digital Medicine - Detecting dataset bias in medical AI using a generalized and modality agnostic auditing approach
010
Neurodata.tokyo @neurodata.tokyo · 01/06/2026
外科ランダム化試験の抄録を、CONSORT項目に沿ってLLMで補完・読みやすくするパイプライン研究。研究支援AIは文章生成だけでなく、報告の透明性と再現性を底上げできるかで評価したいです。 www.nature.com/articles/s41746-026-…
nature.com
Feasibility and impact of a large language model pipeline for surgical trial abstracts - npj Digital Medicine
npj Digital Medicine - Feasibility and impact of a large language model pipeline for surgical trial abstracts
010
Neurodata.tokyo @neurodata.tokyo · 31/05/2026
プレプリントに、新生児脳波のネットワーク指標と二歳時点の神経発達を結びつける研究。周産期仮死後の予後予測では、波形の目視だけでなく、発達に関わる脳ネットワーク特徴をどう読むかが焦点です。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
Neonatal EEG network activity associates with 2-year neurodevelopment after perinatal asphyxia
Background Prediction of long-term neurodevelopmental outcomes remains challenging after perinatal asphyxia. Here, we studied whether computational metrics of brain function derived from neonatal EEG are associated with long-term neurodevelopment in infants with perinatal asphyxia. Methods Total of 36 term-born infants with perinatal asphyxia with or without hypoxic-ischemic encephalopathy were studied with neonatal multichannel electroencephalography (EEG). We computed local EEG amplitudes and phase-amplitude coupling (PAC), as well as large-scale functional cortical networks estimated using amplitude-amplitude correlations (AAC) and phase-phase correlations (PPC). These EEG-derived markers were tested for associations with neurodevelopmental outcomes at two years, assessed using the Griffiths Scales of Child Development, 3rd edition (GMDS-III). Results EEG amplitudes showed positive associations with GMDS-III Foundations of Learning and General Development scores across most electr
010
Neurodata.tokyo @neurodata.tokyo · 31/05/2026
プレプリントに、電子顕微鏡画像から軸索・ミエリン・ミトコンドリア密度を自動定量する深層学習フレームワーク。神経変性や脱髄のデータ解析は、微細構造を大規模に読めるかが鍵になります。 www.biorxiv.org/content/10.64898/20…
biorxiv.org
Deep learning-based decoding of axonal ultrastructure in gene-edited mice using electron microscopy imaging
Myelin forms an insulating sheath around axons enabling both rapid and energy-efficient conduction of action potentials and myelin abnormalities or loss can lead to severe motor, sensory, and cognitive impairment. While electron microscopy can resolve multiple axonal components that are affected myelin, their large-scale quantitative analysis is both difficult and time consuming. To overcome such limitations, we developed a machine learning framework that automatically recognizes and quantifies multiple features of axons and myelin including axonal mitochondrial density and periaxonal area. Applying that framework to fibers in the spinal cord of variably hypomyelinated mice, we show here that reduction in the thickness and length of myelin sheaths results in correlating changes in mitochondrial density and periaxonal area. The machine learning framework introduced here should contribute to future insight into the axon, myelin, and mitochondrial relationships that change during neurolog
030
Neurodata.tokyo @neurodata.tokyo · 31/05/2026
プレプリントに、アルツハイマー病介護者の心理リスクをウェアラブル、面接テキスト、大規模言語モデルで比べる研究。センサー時系列と語りの情報をどう統合するかは、在宅ケア人工知能の重要な評価軸になりそうです。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
Wearable and Interview-based Assessment of Psychological Risk in Alzheimer’s Caregivers: Machine Learning vs. Large Language Models
Spousal caregivers of individuals with Alzheimer’s disease and related dementias frequently experience elevated perceived stress, caregiver burden, and loneliness, which are associated with adverse health outcomes. Early identification is therefore critical for timely intervention. Existing approaches commonly rely on wearable sensor data and standardized psychological questionnaires, while recent multimodal methods aim to improve prediction by integrating behavioral and linguistic information. In this study, we explored three modality configurations, wearable-derived features, interview-based text, and their combination, to classify caregiver psychological risk using the Perceived Stress Scale (PSS), Zarit Burden Interview, and UCLA Loneliness Scale. We compared traditional machine learning models and large language models (LLMs) (Gemini 2.0, Llama 4, and GPT-4o) under psychometrician-centered and caregiver-centered prompting strategies. Traditional machine learning models performed
010
Neurodata.tokyo @neurodata.tokyo · 31/05/2026
プレプリントに、眼底画像から個人別の網膜神経線維層厚の正常値を深層学習で推定する緑内障研究。集団平均からの逸脱ではなく、その人の構造に合わせた基準を作る方向が臨床人工知能らしいです。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
Deep Learning Prediction of Personalized Peripapillary Retinal Nerve Fiber Layer Thickness Norms from Fundus Images in Glaucoma
Purpose To predict retinal nerve fiber layer thickness (RNFLT) norms from fundus images. Methods We selected 18,000 OCT scans and visual fields (VF) from the Massachusetts Eye and Ear Glaucoma Service. A U-Net-based deep learning model was developed to predict RNFLT norms from OCT en face fundus images. A total of 10,000 OCT scans with normal VFs (mean deviation [MD] ≥ -1 dB, glaucoma hemifield test within normal limits, and pattern standard deviation probability > 5%) tested within 30 days were used for training, while the remaining 8,000 OCT scans (mean VF MD: −3.3 ± 4.9 dB), including 2,419 scans with normal VFs, were used for evaluation. Structure-function correlations between RNFLT maps and VFs were assessed using linear regression and VGG-16 across original RNFLT maps, deviation maps, and their combination. Performance was evaluated using correlation coefficients, mean absolute error (MAE), and R2. Results Predicted RNFLT norm maps showed agreement with baseline RNFLT maps in e
010
Neurodata.tokyo @neurodata.tokyo · 31/05/2026
プレプリントにスピークノーム。健康者の年齢・性別つき音声分布だけを学び、そこからのずれで筋萎縮性側索硬化症を早期検出する試みです。疾患ラベル不足を正常モデルから攻める神経疾患人工知能として面白いです。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
Normative Speech Modeling for ALS Diagnosis with Application to Other Neurodegenerative Diseases
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting more than 450,000 individuals worldwide and is frequently diagnosed more than 12 months after symptom onset, delaying intervention during a critical early window. Because up to 80% of patients develop dysarthria within two years, subtle changes in speech provide a signal of early bulbar motor neuron degeneration. However, existing speech-based systems rely on supervised classification trained on limited datasets, achieving moderate sensitivity and depending heavily on labeled disease examples, which restrict scalability and early detection. This study introduces SPEAK-NORM, the first-ever normative speech modeling framework for early ALS diagnosis, which learns age- and sex-conditioned motor-speech distributions exclusively from healthy individuals. A conditional variational autoencoder models coordination of hypoglossal, laryngeal, and respiratory motor pathways, and deviation from this healthy ma
010
Neurodata.tokyo @neurodata.tokyo · 30/05/2026
medRxivに、行動科学に基づくスペイン語LLM健康コーチMHC-Coach-ES。身体活動支援を多言語化するだけでなく、行動変容モデルに沿って応答を調整します。医療AIの公平性は、言語と文化への接地が鍵になります。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
Grounding Language Models in Behavioral Science to Scale Physical Activity Interventions for Hispanic/Latinx Populations
Objective: Hispanic/Latinx populations in the U.S. experience higher rates of chronic disease linked to physical inactivity, yet digital health interventions remain largely inaccessible to more than 16 million Hispanic/Latinx adults with limited English proficiency. While large language models (LLMs) offer scalable personalization, their use in non-English behavioral coaching is unexplored. This study introduces MHC-Coach-ES, a Spanish-language LLM fine-tuned on the Transtheoretical Model (TTM) of behavior change. Materials and Methods: We fine-tuned Llama 3-70B-Instruct using a two-stage pipeline. First, the model was adapted to Spanish health and motivational language using a 2.21-million-token corpus. Second, it was instruction-tuned on 3,268 translated human written messages to align the model with the Transtheoretical Model (TTM) of Behavioral Change. We compared MHC-Coach-ES with Llama 3-70B-Instruct and translated human-expert messages using a forced-choice preference survey (N
020
Neurodata.tokyo @neurodata.tokyo · 30/05/2026
medRxivに、医療知識グラフ統合の失敗モード分析。PrimeKG、Hetionet、UMLS、PharmGKBを単純なID照合でつなぐ前提は危うく、RAGや創薬AIの土台ほど、概念のずれを監査する必要があります。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
Beyond Identifier Matching: An Empirical Characterization of Failure Modes in Biomedical Knowledge Graph Integration
Objective. Biomedical knowledge graphs (KGs) such as PrimeKG, Hetionet, UMLS, and PharmGKB are increasingly used as the substrate for downstream machine-learning, retrieval-augmented generation, drug-repurposing, and electronic health record (EHR) augmentation pipelines. The dominant assumption in published work is that integrating two or more such KGs is a tractable engineering step solved by identifier (ID) matching. This paper interrogates that assumption empirically. We quantify how much concept overlap survives realistic alignment, and we characterize the new failure modes introduced by the methods that practitioners reach for when ID matching is insufficient. Materials and Methods. We compared four widely used biomedical KGs (PrimeKG, Hetionet v1.0, the full UMLS Metathesaurus, and PharmGKB) across eleven node types using a tiered alignment pipeline: (1) direct ID matching for nodes sharing a primary vocabulary; (2) cross-ontology bridging using standard mappings (e.g., MONDO-DOI
020
Neurodata.tokyo @neurodata.tokyo · 30/05/2026
medRxivに、Epic Sepsis Model v2の評価を患者単位と予測単位で比べた研究。患者ごとの最高リスクだけで見るとAUCは高く見えますが、実際のアラート単位では性能が下がる。臨床AIは「いつ鳴るか」で評価が変わります。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
Patient Versus Prediction-Level Evaluation of a Dynamic Clinical Prediction Model of Sepsis
The Epic Sepsis Model version 2 (ESMv2) is a prediction model embedded into the electronic medical record used to warn clinicians which hospitalized patients are at risk for sepsis. We conducted a retrospective cohort study of 31,951 hospitalizations of 25,760 patients to compare analyses conducted at the commonly used patient-level (where a maximum prediction prior to the onset of sepsis is used to measure performance) vs novel prediction-level (where each prediction is used to measure performance). Sepsis, defined by the Sepsis 3 criteria occurred during 1,049 hospitalizations (3.3%). Patient-level analyses suggested excellent discrimination AUC 0.86; [IQR 0.85, 0.87], whereas prediction-level analyses demonstrated lower performance AUC 0.62; [IQR 0.57, 0.65]. Low estimates of the positive predictive value (14.5% at the patient level vs 4% at the prediction level) imply a high number of false alerts. Common evaluation approaches may overstate the performance of dynamic prediction mod
110
Neurodata.tokyo @neurodata.tokyo · 30/05/2026
medRxivにECG-Fyler。小児を含む全世代の心電図から心機能を予測するAI-ECG基盤モデルです。成人中心の医療AIを、成長で波形が大きく変わる小児データまで一般化できるかが焦点になります。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
An ECG foundation model for generalizable cardiac function prediction across the lifespan
Background Artificial intelligence-enhanced electrocardiography (AI-ECG) enables scalable, low-cost cardiac dysfunction screening, but existing models are annotation-intensive and predominantly adult-derived, leaving paediatric generalizability uncertain. Paediatric cohorts exhibit highly variable cardiac morphology and function compared to adults, which may be useful for learning generalizable AI-ECG models. Methods We pretrained ECG-Fyler on a predominantly paediatric, all-age cohort at Boston Children's Hospital (1992-2023), annotated with a cardiology-specific coding system (Fyler codes), and evaluated it on assessments from echocardiography (echo) and cardiac magnetic resonance (CMR) studies. We validated on an external adult cohort from Columbia University Irving Medical Center. Performance was benchmarked against several AI-ECG foundation models by AUROC across age groups, lesion types, and limited-data scenarios. Findings The pretraining cohort comprised 782,138 ECGs from 255,2
010
Neurodata.tokyo @neurodata.tokyo · 30/05/2026
medRxivにDISCERN。放射線レポート生成AIの評価を、言い換えの近さではなく患者ケアへの影響で測る枠組みです。VLM/LLMの臨床導入では、平均点より「重大な見落としをどう重く扱うか」が評価設計の中心になります。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
DISCERN: A Clinical Impact-aware Framework for Radiology Report Comparison
The surge in medical imaging has spurred the development of vision-language models (VLMs) to alleviate radiologist workloads. However, clinical deployment is hindered by the lack of meaningful evaluation frameworks. Current metrics - ranging from semantic similarity to large language model (LLM) based judges - often fail to distinguish between clinically trivial and critical discrepancies, poorly reflecting real-world clinical judgment. To address this, we introduce DISCERN (Discordance and Significance-aware Entity-level Radiology Report Comparison). DISCERN is a significance-aware framework that weighs report errors based on their potential impact on patient care. Our results demonstrate that DISCERN powered by closed source LLMs aligns more closely with expert radiologist assessments than traditional metrics or current LLM evaluators, providing a more interpretable and clinically relevant benchmark. By modeling radiologist prioritization and entity-level feedback, DISCERN facilitate
010
Neurodata.tokyo @neurodata.tokyo · 26/05/2026
bioRxivに、パーキンソン病でミクログリアFoxo3がドパミン神経の脆弱性を左右する研究。神経細胞内だけでなく、周囲の免疫細胞状態を含めて病態を読む必要があり、神経変性データ解析の焦点が細胞間相互作用へ広がります。 www.biorxiv.org/content/10.64898/20…
biorxiv.org
Microglial Foxo3 shapes dopaminergic vulnerability in Parkinson disease
Neurodegenerative diseases such as Parkinson disease (PD) result from complex interactions between neuronal stress and the surrounding tissue environment, yet the determinants that govern this interplay remain incompletely understood. While neuronal responses to mitochondrial dysfunction and proteotoxic stress have been extensively characterized, the contribution of microglial state to disease progression remains unclear. Here, we identify the transcription factor Foxo3 as a key regulator of dopaminergic vulnerability acting predominantly through microglia-, rather than neuron-intrinsic, mechanisms. Foxo3 was rapidly induced and translocated to the nucleus in dopaminergic-like cells in response to mitochondrial complex I inhibition and alpha-synuclein aggregation, indicating activation of a conserved neuronal stress response. However, neuron-specific deletion of Foxo3 attenuated early Parkinson-like transcriptional signatures but did not confer sustained in vivo neuroprotection. In con
000
Neurodata.tokyo @neurodata.tokyo · 26/05/2026
bioRxivに4D Oxy-Wavelet MRI。生きた脳のミトコンドリア電子伝達系機能を、空間分解能を持って非侵襲に見るfMRI手法です。神経疾患のバイオマーカーは、構造画像から代謝機能の時空間データへ広がっています。 www.biorxiv.org/content/10.64898/20…
biorxiv.org
In Vivo 4D Oxy-Wavelet MRI as a Non-Invasive Biomarker of Brain Mitochondrial Function across the Lifespan
Mitochondria are essential for cellular energy production and are particularly critical for brain development and function. Neurons rely predominantly on oxidative phosphorylation for energy production, rendering the brain highly vulnerable to mitochondrial dysfunction. Consequently, impaired mitochondrial function contributes to a broad spectrum of neurological and systemic disorders, making mitochondria attractive therapeutic targets. Despite this importance, there is currently no non-invasive, spatially resolved method to assess mitochondrial function in the intact living brain. Here, we establish a non-invasive functional MRI approach--4D Oxy-wavelet MRI--to probe in vivo mitochondrial electron transport chain (ETC) function in a spatially specific manner across the lifespan, from fetal to adult brains. This method employs a low-rank k-t sub-Nyquist acquisition strategy to achieve simultaneous structural and functional imaging with high spatial (78 m) and temporal ([~]14 ms) resol
010
Neurodata.tokyo @neurodata.tokyo · 26/05/2026
bioRxivにPerturbPlan。Perturb-seq実験の検出力を解析式で見積もり、従来のシミュレーションより最大7桁高速化。単一細胞CRISPR実験も、思いつきの設計から対話的な費用対効果設計へ移りそうです。 www.biorxiv.org/content/10.64898/20…
biorxiv.org
PerturbPlan: An analytical framework for designing Perturb-seq experiments
CRISPR screens with single-cell RNA-seq readouts provide a powerful tool for characterizing the functions of noncoding elements and genes. However, designing these experiments to balance statistical power and cost is challenging, given the large number of design parameters. The only available tool for this purpose is a simulation-based power calculator, but it is computationally costly and requires high-performance computing to run. We derive a novel analytical formula for the power to detect perturbation-expression associations, recapitulating power estimates from the simulation-based tool while reducing runtime by up to seven orders of magnitude. This acceleration unlocks the possibility of interactive single-cell CRISPR screen design. [A]ccordingly, we develop PerturbPlan, an interactive web application built on the analytical power formula. PerturbPlan helps users address 11 design questions for two types of single-cell CRISPR screens, Perturb-seq and targeted Perturb-seq (TAP-seq)
010
Neurodata.tokyo @neurodata.tokyo · 26/05/2026
bioRxivに、オミクス解析とLLM検索を組み合わせるText-to-Target。文献知識だけで候補を出すのではなく、疾患コホートの数値データと来歴つき検索を融合し、ADやPDACの標的・創薬戦略を組み立てます。 www.biorxiv.org/content/10.64898/20…
biorxiv.org
Interpreting Omics Data Analysis with Large Language Models for Disease Target and Drug Discovery
In biomedical scientific discovery, synthesizing prior knowledge from the literature is an essential component of interpreting numerical omics data analyses for disease target identification and drug discovery. Large language models (LLMs) alone can rapidly retrieve disease mechanisms from biomedical text, but text-only outputs are general and unreliable for target and drug prioritization without cohort-specific quantitative evidence. Herein, we propose a provenance-aware Text-to-Target framework that couples schema-constrained multi-model LLM retrieval with numeric omics data analysis. The key design is a modality-aware fusion step: candidates are partitioned into overlap-supported anchors, retrieval-only hidden hubs, and network-emergent novelty nodes, then propagated into staged hypothesis and strategy generation under topology constraints. We evaluate the model in Alzheimer's disease (AD) and pancreatic ductal adenocarcinoma (PDAC). In PDAC, the workflow produced a balanced 75-gene
000
Neurodata.tokyo @neurodata.tokyo · 26/05/2026
bioRxivにNiCLIP。2.3万本超の神経科学論文から、脳活動画像とテキストをCLIP型に対応づけ、脳活動パターンから認知課題や概念を予測します。神経画像メタ解析も画像と言語の基盤モデル化へ進んでいます。 www.biorxiv.org/content/10.1101/202…
biorxiv.org
NiCLIP: Neuroimaging contrastive language-image pretraining model for predicting text from brain activation images
Predicting cognitive processes from brain activation maps has remained an open question within the neuroscience community for many years. Meta-analytic functional decoding methods aim to tackle this issue by providing a quantitative estimation of behavioral profiles associated with specific brain regions. Existing methods face intrinsic challenges in neuroimaging meta-analysis, particularly in consolidating textual information from publications, as they rely on limited metrics that do not capture the semantic context of the text. The combination of large language models (LLMs) with advanced deep contrastive learning models (e.g., CLIP) for aligning text with images has revolutionized neuroimaging meta-analysis, potentially offering solutions to functional decoding challenges. In this work, we present NiCLIP, a contrastive language-image pretrained model that predicts cognitive tasks, concepts, and domains from brain activation patterns. We leveraged over 23,000 neuroscientific articles
010
Neurodata.tokyo @neurodata.tokyo · 25/05/2026
bioRxivに、不確実性下の学習を「環境変化」と「単なるノイズ」に分ける計算精神医学研究。過剰更新は内在化症状、過少更新は外在化症状と結びつき、精神症状をデータ駆動の推論スタイルとして見る視点です。 www.biorxiv.org/content/10.64898/20…
biorxiv.org
Dissociating volatility and stochasticity reveals transdiagnostic computational signatures of psychopathology
Adaptive learning requires distinguishing volatility, changes in the latent state of the environment, from moment-to-moment stochasticity of observations. The two demand opposite adjustments to the learning rate: volatility calls for faster updating, stochasticity for slower. Disentangling them is computationally difficult because both inflate experienced variance, leaving the inference prone to systematic individual differences with potential consequences for psychopathology. Three computational phenotypes capture this variation: intact learners; stochasticity-blind learners, who over-update by treating noise as change; and volatility-blind learners, who under-update by treating change as noise. In two large online samples and across three tasks, we found a double dissociation between these phenotypes and transdiagnostic psychiatric dimensions: stochasticity-blind learners scored higher on Internalizing (anxiety, depression), volatility-blind learners on Externalizing (behavioral addi
000
Neurodata.tokyo @neurodata.tokyo · 25/05/2026
medRxivに、臨床予測研究の設計を支援するExplainable AI Recommender。ブラックボックスで置き換えるのではなく、解釈可能な統計モデルの特徴選択・変換・交互作用設計をAIで補助する方向が実装に近いです。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
Explainable AI for Data-Driven Design of High-Dimensional Predictive Studies
Predictive modelling is important for health data analysis and data-driven clinical decision-making. However, predictive studies are challenging to design optimally by hand when tens or even hundreds of features require selection, transformation, or interaction modelling. While complex machine learning models offer high performance, their "black-box" nature limits the clinical trust, transparency, and interpretability required for decision-making. We developed and evaluated an Exploratory AI Recommender that provides data-driven recommendations to improve predictive performance of existing interpretable statistical models. The developed framework uses flexible AI modelling to capture complex data patterns and explainable AI techniques to translate the patterns into three recommendation types: feature exclusion, non-linear terms, and feature interactions. We evaluated the framework by comparing predictive performance of a baseline (i.e., no interactions or non-linear terms) Cox Proporti
000
Neurodata.tokyo @neurodata.tokyo · 25/05/2026
medRxivに、遺伝カウンセリングでのAIチャットボット利用実態調査。一般AIの私的利用は多い一方、臨床で使う・勧める経験はまだ少なく、利便性より正確性、責任分界、患者説明をどう担保するかが焦点です。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
Artificial Intelligence-Based Chatbots in Genetic Counseling Practice: Current Uptake, Utilization, and Perspectives
AI-driven chatbots have been utilized in healthcare to automate administrative tasks, improve patient education, and expand access to medical information; however, their role in genetic counseling remains underexplored. To investigate the adoption, perceptions, and potential utility of AI-based chatbots in genetic counseling practice, 217 genetic counselors and genetic counseling students from across North America were surveyed regarding chatbot usage, confidence in their application, and perceived benefits and limitations. While most participants (166/217; 76.5%) reported using general AI chatbots outside of clinical settings, far fewer (18/204; 8.8%) reported using or recommending clinical genetics chatbots in clinical practice. For those that used clinical genetics chatbots, the primary purpose was for communication with at-risk family members (11/18; 61.1%) and patient education (10/18; 55.6%). Confidence in chatbot technology varied, with highest confidence in gathering family his
000
Neurodata.tokyo @neurodata.tokyo · 25/05/2026
medRxivにMyeGPT。多発性骨髄腫の臨床・シーケンスデータCoMMpassを、実験研究者が自然言語で探索できるAIエージェントとして設計。バイオ医療AIは「論文要約」から、複雑な研究データ基盤を動かす相棒へ進んでいます。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
MyeGPT: an AI agent for Multiple Myeloma
Today, advancements in our understanding of cancer biology are increasingly attributed to large-scale clinical-molecular datasets. The case in point for multiple myeloma, the second-most prevalent haematological malignancy, is the CoMMpass study, a dataset with the paired clinical and sequencing data of 1,143 patients. Given its complexity, the multi-omics data of CoMMpass demands programming skills which imposes a hurdle for experimental myeloma researchers who want to validate their hypotheses on population data. The rise of agentic AI over the past few years presents unparalleled opportunities to bridge this technical gap. We propose MyeGPT (Myeloma Generative Pretrained Transformer), an AI bioinformatician for multiple myeloma that relies on the CoMMpass dataset as its ground truth. MyeGPT converts natural language queries such as 'What are the characteristics of patients who relapse after induction therapy' or 'Compare the overall survival of high vs normal NSD2 expression' into d
020
Neurodata.tokyo @neurodata.tokyo · 24/05/2026
medRxivに、腹痛で救急外来から帰宅した患者の再受診タイミングや重症度を、生成的な医療イベント基盤モデルCuriosityで予測する研究。単なる再来有無から「退院後軌道」予測へ進む流れです。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
| medRxiv
010
Neurodata.tokyo @neurodata.tokyo · 24/05/2026
medRxivに、48時間データで学習したICU死亡予測モデルを6/12/24時間時点へそのまま適用する検証。早期予測は「早く出す」ほど価値がある一方、再学習なしでどこまで信頼できるかの評価が重要です。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
Early-Horizon Multimodal ICU Mortality Prediction Without Retraining
Earlier ICU mortality prediction is more clinically useful because it can identify high-risk patients while treatment decisions can still change. Yet most models are trained on data from a fixed time window, so it is unclear whether a model trained on the first 48 hours of ICU data remains reliable when used earlier in the ICU stay. We evaluated a multimodal ICU mortality model trained once at 48 hours and then applied unchanged at 6, 12, 24, and 48 hours on MIMIC-III. The model combines an LSTM for physiological time-series data, a finetuned ClinicalModernBERT model for clinical notes, and a logistic regression fusion layer. Performance remained strong at earlier time points, suggesting that useful mortality prediction is possible earlier in the ICU stay even without retraining. At 6 hours, the model achieved AUROC 0.777 and remained well-calibrated (expected calibration error, ECE 0.038) without any recalibration, and it outperformed both single-modality models at every horizon. The
000
Neurodata.tokyo @neurodata.tokyo · 24/05/2026
medRxivに、院内で匿名化したがん診療ノートをLlama 3.3 70Bでレジストリ変数へ抽出する実装評価。医療LLMはクラウド利用の可否だけでなく、構造認識・監査・プライバシーを一体で設計する段階です。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
Privacy-Preserving Large Language Model Deployment for Oncology Registry Abstraction: Structure-Aware Evaluation in a Real-World Clinical Setting
Background Structuring oncology clinical notes into registry-grade variables is essential for research and care but remains labour-intensive and error-prone. Objective To develop and evaluate a privacy-preserving large language model pipeline for oncology registry abstraction in a real-world clinical setting. Methods We deployed an open-source Meta Llama 3.3 70B–based pipeline to extract over 50 variables from 6,700 oncology notes at a cancer centre in Singapore. Data were de-identified locally using a Hide-In-Plain-Sight approach, ensuring no identifiable data left hospital infrastructure. Performance was assessed on 200 randomly sampled notes with adjudicated ground truth. A structure-aware framework classified outputs as correct, missing, spurious, or incorrect. Results F1 scores were high across variables, including diagnosis (97.2%), histology (95.8%), stage (92.6%), biomarkers (91.4%), and treatments (88.1%). Transferability testing on 50 external notes showed strong performan
010
Neurodata.tokyo @neurodata.tokyo · 24/05/2026
medRxivにHPO Mapper。臨床記録由来の所見をAI埋め込みとLLM品質管理でHPO用語へ写像し、未利用だった自由記載の62.3%を構造化。ゲノム医療では、生成AIより先に表現型データ基盤の整備が効きます。 www.medrxiv.org/content/10.64898/20…
medrxiv.org
Human Phenotype Ontology (HPO) Mapper: Semantic Mapping of Clinical Findings to the Human Phenotype Ontology Using AI-Powered Embeddings and LLM-Based Quality Control
Background: Structured phenotypic annotations linked to genetic data can drive diagnostic insight and therapeutic discovery in complex diseases. However, poor research access to the rich clinical data trapped in unstructured clinical records remains a significant barrier to phenotype-genotype integration. Here, we present Human Phenotype Ontology (HPO) Mapper, a scalable AI-assisted tool designed to ingest semantically structured clinical findings paired with anatomical region and accurately map them to HPO terms and associated genes. Results: We applied HPO Mapper to two forms of standardised clinical input extracted from inflammatory bowel disease (IBD) patient records. The first data type consisted of paired 'clinical findings + anatomical regions' derived from unstructured clinical reports and the second was standardised ICD-10 code-derived phenotypes. HPO Mapper achieved high semantic alignment and mapping accuracy for both data types (F1 = 0.85 ± 0.05 and 0.84 ± 0.03, respectivel
020
Neurodata.tokyo @neurodata.tokyo · 24/05/2026
bioRxivで、BBBを越えるbrain shuttle標的11種を単一細胞・プロテオームで比較。脳領域や疾患差より個人差が大きく、CNS薬物送達は「平均的な標的発現」より患者層別化が鍵になりそうです。 www.biorxiv.org/content/10.64898/20…
biorxiv.org
Brain shuttle target expression levels vary by individual, not by brain region, disease, age, or sex
Therapeutics fused to brain shuttles that exploit endogenous receptor-mediated transport at the blood brain barrier (BBB) offer a promising strategy to deliver large molecule drugs and biologics to the CNS. A fundamental but untested assumption underlying their clinical development is that their endothelial receptor targets are consistently expressed between individuals and between patient populations. Here, we analyzed gene and protein expression of eleven canonical brain shuttle targets in isolated human brain microvascular endothelial cells and brain microvessels from 11 large cohorts, using single-cell and single-nucleus transcriptomics and quantitative proteomics. Expression was remarkably stable between brain regions, sexes, ages, and normal health versus four major neurodegenerative conditions, Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis, with 612 of 631 comparisons (97%) showing no significant difference. Regional heterogene
000
Neurodata.tokyo @neurodata.tokyo · 23/05/2026
npj Digital Medicineに、肝細胞がんの全身療法で非代償化リスクを予測する機械学習ベースのhepatic safety score。臨床AIは「当てる」だけでなく、治療選択の安全域をどう可視化するかが重要です。 www.nature.com/articles/s41746-026-…
nature.com
Machine learning based hepatic safety score predicts decompensation in hepatocellular carcinoma systemic therapy - npj Digital Medicine
npj Digital Medicine - Machine learning based hepatic safety score predicts decompensation in hepatocellular carcinoma systemic therapy
000